Ground News

News from Patient Worthy

See all of Patient Worthy’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

Ground News has come across 79 headlines reported on by Patient Worthy during the past 3 months.

Ground News rates Patient Worthy’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Patient Worthy’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Patient Worthy

Where is Patient Worthy located?Patient Worthy's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Patient Worthy News

Alzheimer's Disease

Breakthrough UVa Research Finds HIV Drugs May Prevent Alzheimer’s

100% Center coverage: 3 sources

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of other diseases.See the Story

Golf

Common Psychiatric Medications May Increase Risk of ALS

100% Center coverage: 1 sources

New research shows that people who take certain psychiatric medications may be more likely to develop amyotrophic lateral sclerosis (ALS), which is the most common form of motor neurone disease (MND).See the Story

Germany · Germany

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration

HepaRegeniX announced that the first patient has been dosed in their Phase Ib clinical trial of its lead candidate HRX-215. The trial is evaluating the safety and efficacy of HRX-215, an orally available small-molecule inhibitor of MKK4, in patients undergoing partial liver resection due to liver metastases deriving from colorectal cancer. [HepaRegeniX (GlobeNewswire)] Press Release See the Story

Happy Father’s Day to all Rare Disease Fathers – Patient Worthy

This Father’s Day, Patient Worthy honors the strength, resilience, and unwavering dedication of fathers of children with rare diseases. Their journeys inspire us all and remind us of the vital role they play in their families and communities. These extraordinary dads have been meeting the needs of rare disease children despite the heartbreak they feel […]Read Article

Vitamin B3 Shows Promise in Slowing Rapid Aging in Rare Disease Patients – Patient Worthy

A recent study has revealed that vitamin B3 could offer hope for patients suffering from a rare genetic disorder that causes accelerated aging. As reported by ScienceBlog, researchers found that vitamin B3 supplementation can slow down the progression of symptoms in individuals with Cockayne syndrome, which is a condition characterized by premature aging, impaired development, […]Read Article

Waldenstrom’s Macroglobulinemia & Advocacy: Steven’s Story – Patient Worthy

In 2019 I presented with dark purple spots on my legs, and my neurologist decided to do lab work. My labs showed a high IGM level, so I was then referred to a local oncologist who did a bone marrow biopsy. It was at that time that I was diagnosed with Waldenstrom’s Macroglobulinemia (WM), a […]Healthcare Read Article

[Opinion] Caroline Menzia’s Caregiver Story with FOXG1 Syndrome – Patient Worthy

Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of Patient Worthy. At just 5 months old, my son Corbin was diagnosed with Infantile Spasms (IS), a rare and devastating type of seizure. Corbin was immediately referred to the Neurology […]Opinion Read Article

Hull Man Takes on 100-Mile Cycling Challenge for Rare Disease Awareness – Patient Worthy

A dedicated Hull resident, Jonny Wightman, is preparing to cycle an impressive 100 miles to raise awareness and funds for rare diseases. As reported by Hull Daily Mail, Jonny’s motivation comes from his own experiences living with a rare condition called adrenoleukodystrophy (ALD), an illness that affects the nervous system and adrenal glands. Jonny’s journey […]Cycling · Hull Read Article

Muscular Dystrophy: Experimental Stem Cell Therapy Generates New Heart Tissue – Patient Worthy

The FDA recently informed Muscular Dystrophy News that it has granted orphan drug designation to the experimental drug ISX9-CPC, a product of the IPS Heart company located in Houston, Texas. The designation awarded to the experimental drug is an incentive to accelerate the creation of treatments for rare diseases that affect under 200,000 people in […]Houston, Texas · Houston Read Article

Throwback Thursday: Updates on Patients from Patient Worthy’s Past – Patient Worthy

My symptoms began in 2001 and within 6 months I went from functionally uncomfortable to disabled to the point that I could barely lift myself out of bed because more than 10 minutes of sitting or standing caused intense spasms and pain above and beyond anything I had ever experienced. The simplest of tasks were […]Read Article

Eddie Vedder Shines Light on Rare Disease Advocacy in “Matter of Time” Documentary – Patient Worthy

Pearl Jam front-man Eddie Vedder takes center stage in the new documentary “Matter of Time,” offering fans and viewers a rare, intimate glimpse into his life as both an artist and an advocate. As seen in an exclusive clip shared by Rolling Stone, the film delves into Vedder’s personal reflections, musical inspirations, and his deep […]Read Article

News from Patient Worthy

News from Patient Worthy

Information about Patient Worthy

Media Bias Ratings

Factuality

Ownership

Top Patient Worthy News

Breakthrough UVa Research Finds HIV Drugs May Prevent Alzheimer’s

Common Psychiatric Medications May Increase Risk of ALS

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration

Happy Father’s Day to all Rare Disease Fathers – Patient Worthy

Vitamin B3 Shows Promise in Slowing Rapid Aging in Rare Disease Patients – Patient Worthy

Waldenstrom’s Macroglobulinemia & Advocacy: Steven’s Story – Patient Worthy

[Opinion] Caroline Menzia’s Caregiver Story with FOXG1 Syndrome – Patient Worthy

Hull Man Takes on 100-Mile Cycling Challenge for Rare Disease Awareness – Patient Worthy

Muscular Dystrophy: Experimental Stem Cell Therapy Generates New Heart Tissue – Patient Worthy

Throwback Thursday: Updates on Patients from Patient Worthy’s Past – Patient Worthy

Eddie Vedder Shines Light on Rare Disease Advocacy in “Matter of Time” Documentary – Patient Worthy

Similar News Topics

Topics Most Covered by Patient Worthy

Sources Covering Similar Topics

Breaking News Topics Related to Patient Worthy